Results
Supriya Lifescience Q2 PAT Declines 42% YoY
Supriya Lifescience reported Q2 FY27 revenue growth of 3.2% YoY to ₹206.30 crore but PAT declined 42% due to margin compression.
EBITDA margin contracted to 22.0% from 36.4% due to LATAM regulatory ch
